Expression and significance of IGF-1 and IGF-1R in thyroid nodules

Endocrine

Volumn 44, Issue 1, 2013, Pages 158-164

  Liu, Ying Jian ^a,b   Qiang, Wei ^a   Shi, Jing ^a   Lv, Si Qing ^a   Ji, Mei Ju ^a   Shi, Bing Yin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b FIRST PEOPLE S HOSPITAL OF SHANGQIU   (China)

Author keywords

IGF 1; IGF 1R; Immunohistochemistry; qRT PCR; Thyroid nodules

Indexed keywords

MESSENGER RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; BENIGN TUMOR; CELL INVASION; CELL TRANSFORMATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NODULAR GOITER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID CARCINOMA; THYROID NODULE; TUMOR CELL;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GENE EXPRESSION; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; THYROID NODULE;

EID: 84881120562     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9864-z     Document Type: Article

References (31)

1. J.I. Jones, D.R. Clemmons, Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16(1), 3-34 (1995)
2. D. LeRoith, C.T. Roberts, The insulin-like growth factor system and cancer. Cancer Lett. 195(2), 127-137 (2003)
3. P. Tita, M.R. Ambrosio, C. Scollo et al., High prevalence of differentiated thyroid carcinoma in acromegaly. Clin. Endocrinol. (Oxf). 63(2), 161-167 (2005)
4. H.C. Alpay, T. KalIdag, E. Keles et al., The effects of fine needle biopsy on thyroid hormone levels. Otolaryngol. Head Neck Surg. 136(6), 942-945 (2007)
5. M. Gasperi, E. Martino, L. Manetti et al., Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J. Endocrinol. Invest. 25(3), 240-245 (2002)
6. M. Scacchi, M. Andrioli, C. Carzaniqa et al., Elastosonogra evaluation of thyroid nodules in acromegaly. Eur. J. Endocrinol. 161(4), 607-613 (2009)
7. G. Siegel, Y. Tomel, Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature. Endocr. Res. 31(1), 51-58 (2005)
8. Y.J. Liu, W. Qiang, X.J. Liu et al., Association of insulin-like growth factor-1 with thyroid nodules. Oncol. Lett. 2(6), 1297-1301 (2011)
9. H. Hartog, J. Wesseling, H.M. Boezen et al., The insulin-like growth factor 1 receptor in cancer old focus, new future. Eur. J. Cancer 43(13), 1895-1904 (2007)
10. R. Baserga, The insulin-like growth factor-1 receptor as a target for cancer therapy. Expert. Opin. Ther. Targets 9(4), 753-768 (2005)
11. D. Sachdev, D. Yee, Disrupting insulin-like growth factor signaling as a potential cancer therapy. Mol. Cancer Ther. 6(1), 1-12 (2007)
12. R.E. Humbel, Insulin-like growth factors I and II. Eur. J. Biochem. 190(3), 445-462 (1990)
13. R. Baserga, The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55(2), 249-252 (1995)
14. V.M. Macaulay, Insulin-like growth factors and cancer. Br. J. Cancer 65(3), 311-320 (1992)
15. P. Rotwein, Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 5(1), 3-18 (1991)
16. W. Chao, P.A. D'Amore, IGF-2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev. 19(2), 111-120 (2008)
17. E.J. Mason, J.A. Grell, J. Wan et al., Insulin-like growth factor (IGF)-I and IGF-II contribute differentially to the phenotype of pregnancy associated plasma protein-A knock-out mice. Growth Horm IGF Res. 21(5), 243-247 (2011)
18. E. Maiorano, A. Ciampolillo, G. Viale et al., Insulin-like growth factor 1 expression in thyroid tumors. Appl. Immunohistochem. Mol. Morphol. 8(2), 110-119 (2000)
19. S. Masood, L.J. Auguste, A. Westerband et al., Differential oncogenic expression in thyroid follicular and Hürthle cell carcinomas. Am. J. Surg. 166(4), 366-368 (1993)
20. M.H. Takahashi, G.A. Thomas, E.D. Williams, Evidence for mutual interdependence of epithelium and stromal lymphoid cells in a subset of papillary carcinomas. Br. J. Cancer 72(4), 813-817 (1995)
21. F. Minuto, A. Barreca, P. Del Monte et al., Immunoreactive Insulin-like growth factor 1 (IGF-1) and IGF-1 binding protein content in human thyroid tissue. J. Clin. Endocrinol. Metab. 68(3), 621-626 (1989)
22. T. Yashiro, M. Arai, K. Shizume et al., Increased activity of insulin-like growth factor-binding protein in human thyroid papillary cancer tissue. Jpn. J. Cancer Res. 85(1), 46-52 (1994)
23. E. Surmacz, M. Bartucci, Role of estrogen receptor alpha in modulating IGF-1 receptor signaling and function in breast cancer. J. Exp. Clin. Cancer Res. 23(3), 385-394 (2004)
24. M. Eszlinger, K. Krohn, J. Kratzsch et al., Growth factor expression in cold and hot thyroid nodules. Thyroid 11(2), 125-135 (2001)
25. T. O'Connell, D.R. Clemmons, IGF-1/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms. J. Clin. Endocrinol. Metab. 87(9), 4356-4360 (2002)
26. D.D. Karp, L.G. Paz-Ares, S. Novello et al., Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. J. Clin. Oncol. 27(15), 2516-2522 (2009)
27. D.R. Clemmons, Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat. Rev. Drug Discov. 6(10), 821-833 (2007)
28. P. Haluska, J.M. Carboni, C. TenEyck et al., HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924. Mol. Cancer Ther. 7(9), 2589-2598 (2008)
29. Q.W. Fan, C.K. Cheng, T.P. Nicholaides et al., A dual phosphoinositide-3-kinase α/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma. Cancer Res. 67(17), 7960-7965 (2007)
30. Y. Wang, P. Lipari, X. Wang et al., A fully human insulin-like growth factor-I receptor antibody SCH 717454 (Robatumumab) has antitumor activity as a single agent and in combination with cytotoxics in pediatric tumor xenografts. Mol. Cancer Ther. 9(2), 410-418 (2010)
31. E.J. Gallagher, D. LeRoith, The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol. Metab. 21(10), 610-618 (2010)